Lycia Therapeutics fell approximately 8%
Market Movers·
Lycia Therapeutics
LYCA----
Lycia Therapeutics fell approximately 21%
Market Movers·US IPO Weekly Winners & Losers
RenaissanceCapital·- Recent market volatility and AI sector sell-offs have delayed major initial public offerings like Anthropic, SB Energy, and Nscale. - Despite broader downturns, select companies such as fintech firm OPay and biotech Lycia Therapeutics are proceeding with their listings. - The Renaissance IPO Index fell -1.1 % last week, outpaced by software sector gains while AI infrastructure and electrical equipment names declined.US IPO Weekly Recap: Trickle of biotech activity continues amid tech sell-off
RenaissanceCapital·- Lycia Therapeutics debuted this week by raising $318 million at a $1.1 billion market cap, experiencing a +67% surge. - Four companies submitted initial filings during the week of October 19th, 2026, including biotech firms Rezera and Windward Bio aiming for $100 million each. - Additional filings included Sensing4D AI seeking $35 million and iStep Learning targeting $18 million.